Felice Gragnano: LDL-C Treatment Is Not Enough – Reaching the Target Matters
Felice Gragnano, Associate Professor and Cardiologist at Università Vanvitelli, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Journal of Internal Medicine, adding:
“Being treated is not the same as being protected.
In LDL-C management, treatment initiation is not the finish line. It is the starting line.
The real questions are:
- Has LDL-C been rechecked?
- Has the target been reached?
- Has therapy been intensified when LDL-C remains above target?
A prescription is not a target achieved.
In the Quality Matters initiative evaluating LDL-C management after acute myocardial infarction:
- approximately 1 in 5 patients had no LDL-C reassessment within 6 months
- only approximately 1 in 2 achieved the guideline-recommended LDL-C target
- approximately 2 in 5 had therapeutic inertia (LDL-C above target without treatment optimization).
If we do not recheck and intensify when needed, the LDL-C pathway stops before protection is achieved.
This is not only a lipid gap.
It is an implementation gap – between prescribing and protecting.
If LDL-C is causal, target attainment is not optional.
The LDL-C implementation loop is simple – but it must be closed:
- Measure
- Treat
- Recheck
- Intensify
- Maintain
How can we make LDL-C target attainment a routine quality-of-care metric?”
Title: Diagnostic and therapeutic inertia for LDL cholesterol management of consecutively verified patients with acute myocardial infarction
Authors: Felice Gragnano, Chiara Artana, Greta Carrara, Alice Sacco, Claudio Montalto, Marco Mennuni, Marco Zuin, Fabrizio D’Ascenzo, Fabrizio Del Nevo, Vincenzo De Sio, Leonardo De Luca, Giulia Spoto, Giuseppe Musumeci, Fabrizio Oliva, Gaetano Maria De Ferrari, Daniele Grosseto, Paolo Calabrò, Giuseppe Patti, Gianluca Campo, Sergio Leonardi 
Stay updated with Hemostasis Today.
-
Nov 19, 2026, 10:43Strengthening Plasma Management and Patient Access Across Eastern Europe – ISBT
-
Nov 19, 2026, 10:32Rana Al-Hrout: The Hemodilution Trap – Accurate Blast Assessment in Bone Marrow Biopsies
-
Nov 19, 2026, 10:29Maria Panagiota Terzi: Presenting Research on Coagulation Biomarkers in Acute Myocardial Infarction
-
Nov 19, 2026, 10:21Paola Ranalli: Hemophilia and von Willebrand Disease Advancing Care Through Multidisciplinary Collaboration
-
Nov 19, 2026, 10:11Rana Al-Hrout: Iron Deficiency in Heart Failure – Does It Matter Even Without Anemia?
-
Nov 19, 2026, 10:08Christina Rolling: CAR T-Cell Therapy and Coagulation Disturbances Understanding Severe Hypofibrinogenemia
-
Nov 19, 2026, 09:34Dahlia R.: Immature Platelet Fraction Understanding the Cause of Low Platelet Counts
-
Nov 19, 2026, 07:00Rucha Patil: Highlights in Science and Collaboration at Haematocon 2026
-
Nov 19, 2026, 06:20Suvro Sankha Datta: AABB Releases the 8th Edition of Molecular Testing Standards